Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|4|521-529

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.4, 2014-02, pp. : 521-529

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retinal Abnormalities in Newly Diagnosed Adult Acute Myeloid Leukemia

By  

Acta Haematologica, Vol. 105, Iss. 4, 2001-08 ,pp. : 197-203

Karger

Access to resources Recommend Favorite

Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients

By  

CANCER, Vol. 119, Iss. 23, 2013-12 ,pp. : 4162-4169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Aberrant Expression of Splicing Factors in Newly Diagnosed Acute Myeloid Leukemia

By  

Oncology Research and Treatment, Vol. 35, Iss. 6, 2012-05 ,pp. : 335-340

Karger

Access to resources Recommend Favorite

Intracranial Hemorrhage in Patients Newly Diagnosed with Acute Myeloid Leukemia and Hyperleukocytosis

By  

Acta Haematologica, Vol. 138, Iss. 2, 2017-09 ,pp. : 116-118

Karger

Access to resources Recommend Favorite

Final results of a phase 2 trial of clofarabine and low‐dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia

By  

CANCER, Vol. 121, Iss. 14, 2015-07 ,pp. : 2375-2382

John Wiley & Sons Inc

Access to resources Recommend Favorite